Videra Health: The AI Breakthrough Making Clinical Trials Faster, Smarter, and More Reliable
What is Videra Health? Videra Health is an AI clinical platform that captures and analyses multimodal patient data (asynchronous video, voice, text/chat, and structured questionnaires) to automate assessments, flag risks, and generate quantitative and qualitative outputs for clinicians and research teams. Typical use cases include automated intake, remote patient monitoring, eCOA/ePRO collection, AI-assisted video assessments […]
Feature Categories
What is Videra Health?
Videra Health is an AI clinical platform that captures and analyses multimodal patient data (asynchronous video, voice, text/chat, and structured questionnaires) to automate assessments, flag risks, and generate quantitative and qualitative outputs for clinicians and research teams. Typical use cases include automated intake, remote patient monitoring, eCOA/ePRO collection, AI-assisted video assessments for safety/efficacy signals, and the generation of real-world evidence.
The platform is designed for behavioural health providers and life sciences teams to enhance engagement, adherence, and early intervention while reducing administrative burden. Videra emphasises scalable, HIPAA-aware deployments and tools that support clinical research workflows and post-approval monitoring.
Why Leading Healthcare Teams Trust Videra Health
- FDA-registered digital platform for AI-driven video assessments in healthcare
- Approved as a Behavioral Healthcare Instrument with The Joint Commission
- Raised $5.6M in Seed II funding led by Peterson Ventures with participation from Mercato Partners, Epic Ventures, and Philo Ventures
- Led by internationally recognized healthcare and video-analytic experts
- Leadership recognized in the "AI Utah 100" 2023 Winners for exceptional AI leadership
- Named as one of 12 finalists for the second annual ATA telehealth innovators challenge
- Partnership with Discovery Behavioral Health and collaboration with academic institutions including Kent State University and Brown University
- AI-powered tools monitor video, voice, and text data to detect patient deterioration before visible symptoms appear
- Based in Utah with focus on mental health and behavioral health assessment platforms
- No evidence of major mergers or acquisitions found in current search results
- Privacy policy available but specific HIPAA compliance details require further investigation
Top 3 Pain Points Videra Health Fixes in Healthcare
| Problem | How Videra Health Solves It |
|---|---|
| 1. Low patient engagement & retention in trials | Uses multimodal AI (video, voice, text) to keep patients engaged, improve adherence, and reduce dropout rates. |
| 2. Inefficient, resource-heavy data collection | Automates eCOA/ePRO and remote assessments, cutting manual workload and speeding data capture |
| 3. Missed or delayed risk detection | AI-driven analytics identify behavioral and clinical risk signals early, enabling timely intervention and better trial outcomes. |
Feature Category Summary: Videra Health
| Feature Category | Summary | Association (YES, NO, NA) |
|---|---|---|
| Regulatory-Ready | Videra describes a “secure, multi-modal assessment platform” used for behavioral health and life sciences, but public clinical-trial pages do not explicitly cite 21 CFR Part 11, EMA Annex 11, GxP validation, or FDA/EMA submissions for the platform itself. Security and compliance pages focus on HIPAA and SOC 2 Type II for data protection but do not clearly frame GxP audit-trail design or formal validation for regulated trial systems. No public documentation found for explicit GxP/Part 11 regulatory-ready features. | NA |
| Clinical Trial Support | Videra’s “AI-Powered Clinical Trials” offerings explicitly target trials: “transform clinical trials from screening to analysis,” “streamline screening, enable remote monitoring,” and “capture richer endpoints across all trial phases.” Modules such as Videra Front Door, Intake Manager, Assess, Sidekick Notes, and Sidekick Elevate support AI screening for ideal candidates and protocol adherence, automate pre-screening and consent journeys, capture rich multi-modal eCOA/ePRO data, automatically document research sessions, and monitor researcher–subject interactions to maintain protocol fidelity. | YES |
| Supply Chain & Quality | The platform focuses on trial recruitment, engagement, eCOA/ePRO, and safety/risk monitoring in behavioral health and neurology; there is no mention of drug manufacturing QA, batch release, or counterfeit-detection capabilities. No public documentation found for supply-chain or manufacturing-quality features. | NA |
| Efficiency & Cost-Saving | Videra highlights that its multimodal AI “streamlines trial operations through automated data collection,” reduces site burden, decreases protocol deviations, and enables decentralized designs, allowing patients to complete brief video assessments from any device. By automatically identifying ideal candidates, automating pre-screening and consent, transforming sessions into structured notes, and generating early safety signals, the platform reduces coordinator workload and accelerates decision-making, directly framed as improving trial efficiency and lowering operational burden. | YES |
| Scalable / Enterprise-Grade | Videra markets a “Clinical AI platform that transforms behavioral health and pharma” with multimodal AI “used in 75,000+ patients,” and positions its solutions for health systems, payers, and life-sciences organizations. The HIPAA/SOC 2 Type II-compliant cloud infrastructure on AWS with multi-AZ deployment, continuous monitoring, and third-party penetration testing further supports an enterprise-grade deployment model. | YES |
| HIPAA Compliant | Videra’s security and compliance page explicitly states that the company holds “SOC 2 Type II and HIPAA compliance” and “adheres to the highest security standards, including full compliance with HIPAA regulations,” with encryption, strict access controls, and continuous monitoring. The platform is positioned for clinical behavioral health and clinical trials, handling PHI with privacy safeguards aligned to HIPAA and related healthcare-security best practices. | YES |
| Clinically Validated | For pharmaceutical/life sciences use, Videra states that “clinically-validated AI monitoring” strengthens protocol fidelity and that its “validated algorithms [have been] used in 75,000+ patients,” specifically in neurology/post-market contexts. Broader platform copy cites early risk detection and improved safety signals, and external clinical-trial/evidence pages identify Videra as having clinical evidence in behavioral health and psychiatric monitoring, though detailed peer-reviewed trial citations are not enumerated on the marketing pages. There is explicit wording of clinically validated algorithms used at scale. | YES |
| EHR Integration | Videra Health’s main site and clinical pages emphasize integration into clinical workflows and mention partnerships like BestNotes integration for “Sidekick” AI-assisted notes, but do not explicitly reference HL7/FHIR or direct EHR/EMR integration across major hospital systems. Public documentation focuses more on provider platform integrations and APIs than on named EHR standards; explicit EHR-integration claims for the clinical-trial solution are not clearly documented. No public documentation found for direct EHR integration in the clinical-trial context. | NA |
| Explainable AI | Videra highlights “multi-modal analysis (video, voice, language, and movement)” and communicates that its AI provides “real-time patient insights” and “risk detection that goes beyond single-point assessments,” but the trial and pharma pages do not describe user-facing explanation tools (e.g., saliency, feature-importance, or rationales) for why a patient is flagged at risk. Ethical AI materials focus on fairness, diverse datasets, and reliability, not on specific explainability interfaces. No public documentation found for explicit explainable-AI features. | NA |
| Real-Time Analytics | Videra repeatedly emphasizes “real-time patient insights,” “real-time safety signals and efficacy markers,” and “early detection” of deterioration before human observers can see it, based on continuous multimodal video/voice/text data. The pharma/life-sciences page explicitly notes that Videra’s AI helps “strengthen protocol fidelity, risk detection, and targeted engagement” via ongoing monitoring, providing earlier safety signals and richer endpoint data between visits. This constitutes real-time or near-real-time analytics over patient-level trial data. | YES |
| Bias Detection | Videra’s Ethical AI Commitment states that it develops systems using “diverse datasets to minimize biases and help ensure equitable treatment for all patient demographics,” and describes internal processes for fairness evaluation and mitigation. Additional content on model cards for AI vendors emphasizes the importance of “Bias Evaluation: Assessment of potential biases in the model and steps taken to mitigate them” and encourages transparency about these evaluations and regulatory status for healthcare AI tools. Although detailed bias-metric dashboards are not shown, there is explicit recognition and evaluation of bias in models as part of Videra’s AI-governance framework. | YES |
| Ethical Safeguards | Videra’s Ethical AI page outlines principles including fairness, transparency, accountability, and human oversight, stating that clinicians remain central decision-makers and that AI outputs are designed to augment, not replace, clinical judgment. Security-compliance materials describe robust governance (HIPAA, SOC 2 Type II, access controls, encryption, continuous monitoring), and content on model cards stresses documenting use cases, performance boundaries, bias evaluation, and regulatory status, all of which constitute governance controls around AI use in healthcare and trials. | YES |
Risks & Limitations: Videra Health
-
Case-study bias: many headline metrics are case-study results; validate with an on-scope pilot for your population and endpoints.
-
Data & image quality sensitivity: performance depends on video/audio quality and patient compliance with assessments.
-
Regulatory/compliance work: even with registered components, local privacy laws, consent and clinical governance require institutional review before production use.
-
Clinical validation scope: translate algorithmic alerts into clinical pathways and staffing processes to avoid alert fatigue and ensure safe escalation.
Tags
Share This AI Tool
Get a neutral, no obligation view of whether this AI tool fits your portfolio
Stephen
Founder of HealthyData.Science · 20+ years in life sciences compliance & software validation · MSc in Data Science & Artificial Intelligence.